453 related articles for article (PubMed ID: 8475928)
21. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.
Badiou S; Merle De Boever C; Dupuy AM; Baillat V; Cristol JP; Reynes J
Atherosclerosis; 2004 Feb; 172(2):273-9. PubMed ID: 15019537
[TBL] [Abstract][Full Text] [Related]
22. Characterization of low-density lipoprotein subclasses in children.
Arisaka O; Fujiwara S; Yabuta K; Mokuno H; Mitugi Y; Miyake N
Metabolism; 1997 Feb; 46(2):146-8. PubMed ID: 9030819
[TBL] [Abstract][Full Text] [Related]
23. Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuria.
Karabina SA; Pappas H; Miltiadous G; Bairaktari E; Christides D; Tselepis A; Elisaf M; Siamopoulos K
Nephron Clin Pract; 2003; 95(3):c77-83. PubMed ID: 14646367
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
[TBL] [Abstract][Full Text] [Related]
25. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
[TBL] [Abstract][Full Text] [Related]
26. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.
Vohl MC; Tchernof A; Dionne FT; Moorjani S; Prud'homme D; Bouchard C; Nadeau A; Lupien PJ; Després JP
Diabetes; 1996 Oct; 45(10):1405-11. PubMed ID: 8826978
[TBL] [Abstract][Full Text] [Related]
27. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size.
Tribble DL; Holl LG; Wood PD; Krauss RM
Atherosclerosis; 1992 Apr; 93(3):189-99. PubMed ID: 1590824
[TBL] [Abstract][Full Text] [Related]
28. Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men.
Halle M; Berg A; Keul J; Baumstark MW
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):144-8. PubMed ID: 8548415
[TBL] [Abstract][Full Text] [Related]
29. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
30. Alcohol dose and low density lipoprotein heterogeneity in squirrel monkeys (Saimiri sciureus).
Hojnacki JL; Cluette-Brown JE; Dawson M; Deschenes RN; Mulligan JJ
Atherosclerosis; 1992 Jun; 94(2-3):249-61. PubMed ID: 1632875
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein profile in patients who survive a stroke.
Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
[TBL] [Abstract][Full Text] [Related]
32. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
33. Women have a larger and less atherogenic low density lipoprotein particle size than men.
Nikkilä M; Pitkäjärvi T; Koivula T; Solakivi T; Lehtimäki T; Laippala P; Jokela H; Lehtomäki E; Seppä K; Sillanaukee P
Atherosclerosis; 1996 Jan; 119(2):181-90. PubMed ID: 8808495
[TBL] [Abstract][Full Text] [Related]
34. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia.
Maruyama C; Imamura K; Teramoto T
J Atheroscler Thromb; 2003; 10(3):186-91. PubMed ID: 14564088
[TBL] [Abstract][Full Text] [Related]
35. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men.
Krauss RM; Dreon DM
Am J Clin Nutr; 1995 Aug; 62(2):478S-487S. PubMed ID: 7625363
[TBL] [Abstract][Full Text] [Related]
36. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
37. Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns.
Dreon DM; Fernstrom HA; Williams PT; Krauss RM
Am J Clin Nutr; 2000 Jun; 71(6):1611-6. PubMed ID: 10837306
[TBL] [Abstract][Full Text] [Related]
38. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
39. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker.
Berends AMA; Buitenwerf E; Gruppen EG; Sluiter WJ; Bakker SJL; Connelly MA; Kerstens MN; Dullaart RPF
Clin Endocrinol (Oxf); 2019 Jan; 90(1):79-87. PubMed ID: 30372543
[TBL] [Abstract][Full Text] [Related]
40. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1993 May; 13(5):712-9. PubMed ID: 8485123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
